Effect of Inhaled Salmeterol/fluticasone Propionate Combination on Expression of Platelet Membrane Protein Molecules in Patients with Asthma

LEI Wei,HUANG Jian-an,CHEN Yan-bin,YU Ge-hua,ZHANG Xue-guang
DOI: https://doi.org/10.3969/j.issn.1004-583x.2005.17.005
2005-01-01
Abstract:Objective To investigate the effect of inhaled salmeterol/fluticasone propionate combination(seretide) on expression of platelet membrane protein molecules in patients with asthma.Methods Platelets were isolated from 29 patients with asthma,before and after inhaled salmeterol and fluticasone 3 months,the expression rates of platelet membrane protein molecules CD62P,CD40 ligand(CD40L) were measured by flow cytometry.Meanwhile the pulmonary function of all participants were evaluated,the relationship between pulmonary function and the expression of platelet membrane protein molecules was analysed.Results The expression of platelet membrane protein molecules CD62P,CD40L were ((46.7)±(12.8)) %,((21.1)±(7.4)) % in patients with acute asthma group,which were significantly increased as compared with control group(n=15)(P(0.01)),they were negatively correlated with their FEV_1% in predicted value(r=(-0.541),P(0.01);r=(-0.506),P(0.01)).After long-term inhaled salmeterol and fluticasone therapy,the expression of CD62P,CD40L were ((11.8)±(4.7)) % and ((5.3)±(2.9)) %,which were significantly declined compared with those before therapy(P(0.01)).Conclusion There was high level expression of platelet membrane protein molecules CD62P,CD40L in patients with acute asthma,and the level was negatively correlated with its pulmonary function,long-term inhaled salmeterol and fluticasone could inhibit the expression of CD62P,CD40L.Perhaps platelet was another target cell of long-term inhaled salmeterol and fluticasone therapy for asthma.
What problem does this paper attempt to address?